143 related articles for article (PubMed ID: 19876920)
21. Structural and functional impacts of E5 genetic variants of human papillomavirus type 31.
Silva RCO; da Silva Júnior AHP; Gurgel APAD; Barros Junior MR; Santos DL; de Lima RCP; Batista MVA; Pena LJ; Chagas BS; Freitas AC
Virus Res; 2020 Dec; 290():198143. PubMed ID: 32871208
[TBL] [Abstract][Full Text] [Related]
22. A glutamine residue in the membrane-associating domain of the bovine papillomavirus type 1 E5 oncoprotein mediates its binding to a transmembrane component of the vacuolar H(+)-ATPase.
Goldstein DJ; Kulke R; Dimaio D; Schlegel R
J Virol; 1992 Jan; 66(1):405-13. PubMed ID: 1370089
[TBL] [Abstract][Full Text] [Related]
23. The E5 oncoprotein of human papillomavirus type 16 transforms fibroblasts and effects the downregulation of the epidermal growth factor receptor in keratinocytes.
Straight SW; Hinkle PM; Jewers RJ; McCance DJ
J Virol; 1993 Aug; 67(8):4521-32. PubMed ID: 8392596
[TBL] [Abstract][Full Text] [Related]
24. Oligomerization of the E5 protein of human papillomavirus type 16 occurs through multiple hydrophobic regions.
Gieswein CE; Sharom FJ; Wildeman AG
Virology; 2003 Sep; 313(2):415-26. PubMed ID: 12954209
[TBL] [Abstract][Full Text] [Related]
25. Structural role of the conserved cysteines in the dimerization of the viral transmembrane oncoprotein E5.
Windisch D; Hoffmann S; Afonin S; Vollmer S; Benamira S; Langer B; Bürck J; Muhle-Goll C; Ulrich AS
Biophys J; 2010 Sep; 99(6):1764-72. PubMed ID: 20858420
[TBL] [Abstract][Full Text] [Related]
26. Multiple transmembrane amino acid requirements suggest a highly specific interaction between the bovine papillomavirus E5 oncoprotein and the platelet-derived growth factor beta receptor.
Nappi VM; Petti LM
J Virol; 2002 Aug; 76(16):7976-86. PubMed ID: 12134002
[TBL] [Abstract][Full Text] [Related]
27. Downregulation of major histocompatibility complex class I in bovine papillomas.
Araibi EH; Marchetti B; Ashrafi GH; Campo MS
J Gen Virol; 2004 Oct; 85(Pt 10):2809-2814. PubMed ID: 15448341
[TBL] [Abstract][Full Text] [Related]
28. Overexpression, purification, and structural analysis of the hydrophobic E5 protein from human papillomavirus type 16.
Yang DH; Wildeman AG; Sharom FJ
Protein Expr Purif; 2003 Jul; 30(1):1-10. PubMed ID: 12821315
[TBL] [Abstract][Full Text] [Related]
29. Mutation of the bovine papillomavirus E5 oncoprotein at amino acid 17 generates both high- and low-transforming variants.
Sparkowski J; Anders J; Schlegel R
J Virol; 1994 Sep; 68(9):6120-3. PubMed ID: 8057494
[TBL] [Abstract][Full Text] [Related]
30. Cellular transformation by a transmembrane peptide: structural requirements for the bovine papillomavirus E5 oncoprotein.
Meyer AN; Xu YF; Webster MK; Smith AE; Donoghue DJ
Proc Natl Acad Sci U S A; 1994 May; 91(11):4634-8. PubMed ID: 8197111
[TBL] [Abstract][Full Text] [Related]
31. Compensatory mutants of the bovine papillomavirus E5 protein and the platelet-derived growth factor β receptor reveal a complex direct transmembrane interaction.
Edwards AP; Xie Y; Bowers L; DiMaio D
J Virol; 2013 Oct; 87(20):10936-45. PubMed ID: 23926343
[TBL] [Abstract][Full Text] [Related]
32. The human papillomavirus type 16 E5 oncoprotein synergizes with EGF-receptor signaling to enhance cell cycle progression and the down-regulation of p27(Kip1).
Pedroza-Saavedra A; Lam EW; Esquivel-Guadarrama F; Gutierrez-Xicotencatl L
Virology; 2010 Apr; 400(1):44-52. PubMed ID: 20144468
[TBL] [Abstract][Full Text] [Related]
33. Effects of human papillomavirus type 16 E5 deletion mutants on epithelial morphology: functional characterization of each transmembrane domain.
Barbaresi S; Cortese MS; Quinn J; Ashrafi GH; Graham SV; Campo MS
J Gen Virol; 2010 Feb; 91(Pt 2):521-30. PubMed ID: 19812262
[TBL] [Abstract][Full Text] [Related]
34. Glycogene expression profiles from a HaCaT cell line stably transfected with HPV16 E5 oncogene.
Cisneros-Ramírez D; Martínez-Laguna Y; Martínez-Morales P; Aguilar-Lemarroy A; Jave-Suárez LF; Santos-López G; Reyes-Leyva J; Vallejo-Ruiz V
Mol Med Rep; 2020 Dec; 22(6):5444-5453. PubMed ID: 33174037
[TBL] [Abstract][Full Text] [Related]
35. Human papillomavirus 16/18 E5 promotes cervical cancer cell proliferation, migration and invasion in vitro and accelerates tumor growth in vivo.
Liao S; Deng D; Zhang W; Hu X; Wang W; Wang H; Lu Y; Wang S; Meng L; Ma D
Oncol Rep; 2013 Jan; 29(1):95-102. PubMed ID: 23128977
[TBL] [Abstract][Full Text] [Related]
36. E5 oncoprotein transmembrane mutants dissociate fibroblast transforming activity from 16-kilodalton protein binding and platelet-derived growth factor receptor binding and phosphorylation.
Sparkowski J; Mense M; Anders J; Schlegel R
J Virol; 1996 Apr; 70(4):2420-30. PubMed ID: 8642670
[TBL] [Abstract][Full Text] [Related]
37. Simian and human immunodeficiency virus Nef proteins use different surfaces to downregulate class I major histocompatibility complex antigen expression.
Swigut T; Iafrate AJ; Muench J; Kirchhoff F; Skowronski J
J Virol; 2000 Jun; 74(12):5691-701. PubMed ID: 10823877
[TBL] [Abstract][Full Text] [Related]
38. The human papillomavirus type 16 E5 oncoprotein inhibits epidermal growth factor trafficking independently of endosome acidification.
Suprynowicz FA; Krawczyk E; Hebert JD; Sudarshan SR; Simic V; Kamonjoh CM; Schlegel R
J Virol; 2010 Oct; 84(20):10619-29. PubMed ID: 20686024
[TBL] [Abstract][Full Text] [Related]
39. Identification of key amino acid residues that determine the ability of high risk HPV16-E7 to dysregulate major histocompatibility complex class I expression.
Heller C; Weisser T; Mueller-Schickert A; Rufer E; Hoh A; Leonhardt RM; Knittler MR
J Biol Chem; 2011 Apr; 286(13):10983-97. PubMed ID: 21321113
[TBL] [Abstract][Full Text] [Related]
40. In vitro dimerization of the bovine papillomavirus E5 protein transmembrane domain.
Oates J; Hicks M; Dafforn TR; DiMaio D; Dixon AM
Biochemistry; 2008 Aug; 47(34):8985-92. PubMed ID: 18672907
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
